Imnovid

Company:
Bristol-Myers Squibb Pharma EEIG
Status:
No Recent Update
Legal Category:
Product subject to restricted prescription (C)
Active Ingredient(s):
Pomalidomide
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/13/850/001

1 milligram(s)

L04AX,L04AX06

Capsule, hard

EU/1/13/850/002

2 milligram(s)

L04AX,L04AX06

Capsule, hard

EU/1/13/850/003

3 milligram(s)

L04AX,L04AX06

Capsule, hard

EU/1/13/850/004

4 milligram(s)

L04AX,L04AX06

Capsule, hard